Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
03/31/2005 | US20050069862 Frozen or freeze-dried culture comprising inosine-5'-monophosphate for use as starter culture in feed and food products |
03/31/2005 | US20050069562 Animal product free media and processes for obtaining a botulinum toxin |
03/31/2005 | US20050069560 Immunosuppressant prodigiosin; pure culture; transplatation of organs, tissues |
03/31/2005 | US20050069559 Lawsonia intracellularis vaccine |
03/31/2005 | US20050069557 A protein neuroglobin derived from neuronal tissue; binging, storage oxygen; therapy for central nervous system disorders |
03/31/2005 | US20050069535 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
03/31/2005 | US20050069524 Methods for insertion of nucleic acids into circular vectors |
03/31/2005 | US20050069505 Orally administrable composition for the photoprotection of the skin |
03/31/2005 | US20050069491 Dna sequences encoding detectable cytotoxic protein generating signal; tumor imaging; gene expression |
03/31/2005 | DE10341272A1 Preparing genetically modified Blakeslea, useful for preparation of carotenoids, useful as food additives, cosmetics or pharmaceuticals, comprises transformation, optional homokaryotizing, and selection |
03/31/2005 | DE102004042818A1 Automatisiertes biologisches Kultivierungs- und Verteilungs-System Automated biological cultivation and distribution system |
03/31/2005 | CA2540138A1 Recombinant antibody against human insulin-like growth factor |
03/31/2005 | CA2539074A1 Campylobacter polypeptides and methods of use |
03/31/2005 | CA2539065A1 Coumpounds for neutralising the effects of secreted pla2 iia |
03/30/2005 | EP1518929A1 Novel genes |
03/30/2005 | EP1518558A2 Vaccine against infection with Actinobacillus pleuropneumoniae comprising purified ApxIV toxin |
03/30/2005 | EP1518121A2 Novel bartonella antigen lysate extracts for use in elisa diagnostic |
03/30/2005 | EP1517998A2 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
03/30/2005 | EP1517994A2 Flocculation with divalent salt |
03/30/2005 | EP1517992A2 Retrons for gene targeting |
03/30/2005 | EP1517986A2 Bacterial cell digestion |
03/30/2005 | EP1517923A2 Compositions and methods for inhibiting microbial adhesion |
03/30/2005 | EP1517917A2 Human erg2 potassium channel |
03/30/2005 | EP1517913A2 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins |
03/30/2005 | EP1517729A1 Method of producing organic material and use of the same |
03/30/2005 | EP1517701A2 Lewis y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof |
03/30/2005 | EP1517699A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
03/30/2005 | EP1224298B1 Fibrinolytically active polypeptide |
03/30/2005 | EP1187925B1 Pectate lyase fusion for expression and secretion of polypeptides |
03/30/2005 | EP1185867B1 Method for separating cells using immunorosettes |
03/30/2005 | EP1047777B1 Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
03/30/2005 | EP1025241B1 Multiply-substituted protease variants |
03/30/2005 | EP1001978B1 Angiotensin derivatives |
03/30/2005 | CN2688718Y Spiral pipe optical biological reactor |
03/30/2005 | CN1602359A Methods of preparing a targeting vector and uses thereof |
03/30/2005 | CN1602358A Recombinant fusion proteins and the trimers thereof |
03/30/2005 | CN1602357A Novel phytases and method for producing these phytases |
03/30/2005 | CN1602356A Transgenic organism expressing fungal MRP-like ABC transporters |
03/30/2005 | CN1602354A Human coagulation factor VII polypeptides |
03/30/2005 | CN1602317A Angiopoietin-2 specific binding agents |
03/30/2005 | CN1602204A Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
03/30/2005 | CN1602201A Peptides and related compounds having thrombopoietic activity |
03/30/2005 | CN1602154A Inhibition of the asexual reproduction of fungi |
03/30/2005 | CN1600862A Clone and application of alcohol fermentation gene of unit cell fungus through motion ferment |
03/30/2005 | CN1600850A Unit cell fungus, engineering fungus prepared through motion ferment and application |
03/30/2005 | CN1600849A Bacilluscoli 0157 gene deficiency bacterin of intestinal hemorrhage |
03/30/2005 | CN1600848A Liquid nutrient medium for artificial cultural ganoderma lucidum and cultivation method |
03/30/2005 | CN1600847A Artificial cultivated ganoderma lucidum rich in germanium and method of growth in liquor |
03/30/2005 | CN1600750A Method for producing multifunctional organic fertilizer of microbe |
03/30/2005 | CN1600368A Attenuated live vaccine of eel vibrio |
03/30/2005 | CN1600169A Technique for preparing vinegar spicy eggs |
03/30/2005 | CN1195062C Non-antibiotics resistant shuttle plasmid expression carrier and its constructing method and uses |
03/30/2005 | CN1195054C Nikemycin Z component engineering bacterium and its application |
03/30/2005 | CN1195053C 食线虫真菌 Nematophagous fungi |
03/30/2005 | CN1194758C Vaginal lactobacillus medicant |
03/30/2005 | CN1194707C Use of lactobacillus casei in immunostimulatory peptides |
03/30/2005 | CN1194624C Multiple microorganism straw fermented fodder and leaven and its preparing method |
03/29/2005 | US6872870 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
03/29/2005 | US6872814 Chlamydia antigens and corresponding DNA fragments and uses thereof |
03/29/2005 | US6872788 Contacting alkene with microorganism which epoxidizes and converts alkene to carboxylic acid |
03/29/2005 | US6872567 Propagating and recovering preferential cells from culture; obtain cell sample, expose to antibody, separate cells bound to antibody, recover and propagate bound cells |
03/29/2005 | US6872564 Method of producing copolymer polyester |
03/29/2005 | US6872562 For effecting N2 fixation, nodulation, growth and yield of herbicide resistant or tolerant leguminous plants treated with glyphosate |
03/29/2005 | US6872560 Human hydrolytic enzymes |
03/29/2005 | US6872558 Heparanase-2 a member of the heparanase protein family |
03/29/2005 | US6872556 Invention provides DNAs, vectors and host cells for the efficient production of various enzymes in the mevalonate pathway or for converting isopentyl pyrophosphate to farnesyl pyrophosphate synthase |
03/29/2005 | US6872555 Nucleotide sequences for use in generating fructose polymers for food processing |
03/29/2005 | US6872553 Nucleotide sequences which code for the pck gene |
03/29/2005 | US6872551 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
03/29/2005 | US6872525 Method for selectively separating live cells expressing a specific gene |
03/29/2005 | US6872411 Process for the manufacture of probiotic cheese |
03/29/2005 | US6872399 Dermatomycosis vaccine |
03/29/2005 | US6872393 Polyalkylene oxide-modified single chain polypeptides |
03/29/2005 | US6872391 Nucleotide sequences coding polypeptide for use in the treatment of eating disorders |
03/29/2005 | US6872357 Comprises viruses/cells and methylated mono-/di-/oligo-saccharides |
03/29/2005 | CA2323506C Mammalian blood loss-induced gene, kd312 |
03/29/2005 | CA2139667C Methods and diagnostic kits for determining toxicity utilizing bacterial stress promoters fused to reporter genes |
03/29/2005 | CA2072023C Polypeptides involved in the biosynthesis of cobalamines and/or cobamides, dna sequences coding for theses polypeptides, and their preparation and use |
03/24/2005 | WO2005026365A1 A thermophilic host-vector system |
03/24/2005 | WO2005026340A1 Pyrroloquinoline quinone (pqq)-dependent glucose dehydrogenase modification having excellent substrate specificity |
03/24/2005 | WO2005026331A2 Method of preparation of pharmaceutically grade plasmid dna |
03/24/2005 | WO2005026330A1 Matrix derived from whole organ |
03/24/2005 | WO2005026327A2 Biosynthetic gene cluster for leptomycins |
03/24/2005 | WO2005026203A2 Dna promoters and anthrax vaccines |
03/24/2005 | WO2005025490A2 Novel polyol macrolide antitumor-antibiotics from the novel marine actinomycete strain cnq140 |
03/24/2005 | WO2005009581A3 Methods and apparatus for blood separation and analysis using membranes on an optical bio-disc |
03/24/2005 | WO2005005773A3 A process for enhanced recovery of crude oil from oil wells using novel microbial consortium |
03/24/2005 | WO2004111074A9 In vivo production of a clostridial neurotoxin light chain peptide |
03/24/2005 | WO2004099384A3 Solid phase cell lysis and capture platform |
03/24/2005 | WO2004087894A3 Bacterial aggregates |
03/24/2005 | WO2004081171A3 Variants of enzymes of the alpha-amylase family |
03/24/2005 | WO2004076644A3 A composition for delivering an agent to a target cell and uses thereof |
03/24/2005 | WO2004074318A3 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof. |
03/24/2005 | WO2004020406A3 Variants of vibrio cholerae o1 biotype e1 tor with attributes of classical biotype |
03/24/2005 | WO2003087134A3 G-protein coupled receptor ligands and methods |
03/24/2005 | WO2003062380A3 Multiply-substituted protease variants |
03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
03/24/2005 | US20050066384 Using plasmid to enhance site-specific and/or homologous recombination between heterologous gene sequences and host nuclear DNA; tissue engineering and exogenous gene expression in plants |
03/24/2005 | US20050065332 Global suppressors of p53 mutations |
03/24/2005 | US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders |